Cervical Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Cervical Cancer, including details on symptoms, vaccine, screening, treatment, human papilloma virus (hpv), information.

Volume 3 (2006), Issue 12 (December)

1. Cervical intraepithelial neoplasia in adolescent women: incidence and treatment outcomes.
   Obstet Gynecol, 108(6): 1369-74. [Abstract] [Full-text]
2. Functional expression of voltage-gated sodium channels in primary cultures of human cervical cancer.
   J Cell Physiol, 210(2): 469-78. [Abstract] [Full-text]
3. Risk of cervical cancer associated with Chlamydia trachomatis antibodies by histology, HPV type and HPV cofactors.
   Int J Cancer, 120(3): 650-5. [Abstract] [Full-text]
4. Geostatistical analysis of disease data: accounting for spatial support and population density in the isopleth mapping of cancer mortality risk using area-to-point Poisson kriging.
   Int J Health Geogr, 5: 52. [Abstract] [Full-text]
5. Ceramide induces early and late apoptosis in human papilloma virus+ cervical cancer cells by inhibiting reactive oxygen species decay, diminishing the intracellular concentration of glutathione and increasing nuclear factor-kappaB translocation.
   Anticancer Drugs, 18(2): 149-59. [Abstract] [Full-text]
6. "Sip volume" as a quality indicator in liquid-based cervical cytology.
   Cancer, 108(6): 462-7. [Abstract] [Full-text]
7. Human papillomavirus testing using hybrid capture II with SurePath collection: initial evaluation and longitudinal data provide clinical validation for this method.
   Cancer, 108(6): 468-74. [Abstract] [Full-text]
8. A comparison of the clinical utility of p16(INK4a) immunolocalization with the presence of human papillomavirus by hybrid capture 2 for the detection of cervical dysplasia/neoplasia.
   Cancer, 108(6): 451-61. [Abstract] [Full-text]
9. Alternating high-risk human papillomavirus infection: consequences of progression to cervical intraepithelial neoplasia.
   Cancer, 108(6): 475-9. [Abstract] [Full-text]
10. Detection of cervical high-grade squamous intraepithelial lesions from cytologic samples using a novel immunocytochemical assay (ProEx C).
    Cancer, 108(6): 494-500. [Abstract] [Full-text]
11. Early invasive cervical cancer: tumor delineation by magnetic resonance imaging, computed tomography, and clinical examination, verified by pathologic results, in the ACRIN 6651/GOG 183 Intergroup Study.
    J Clin Oncol, 24(36): 5687-94. [Abstract] [Full-text]
12. Activation of p53 in cervical cancer cells by human papillomavirus E6 RNA interference is transient, but can be sustained by inhibiting endogenous nuclear export-dependent p53 antagonists.
    Cancer Res, 66(24): 11817-24. [Abstract] [Full-text]
13. Clinical implications of osteopontin in metastatic lesions of uterine cervical cancers.
    Cancer Lett, 247(1): 98-102. [Abstract] [Full-text]

© 2004-2008 Cervical Cancer Research Today. All Rights Reserved.